| Literature DB >> 35542058 |
Xu Zhou1, Long Yuan2, Chengzhou Wu3, Gaoxing Luo4, Jun Deng4, Zhengwei Mao5.
Abstract
The field of stem-cell-therapy offers considerable promise as a means of delivering new treatments for a wide range of diseases. Recent progress in nanotechnology has stimulated the development of multifunctional nanomaterials (NMs) for stem-cell-therapy. Several clinical trials based on the use of NMs are currently underway for stem-cell-therapy purposes, such as drug/gene delivery and imaging. However, the interactions between NMs and stem cells are far from being completed, and the effects of the NMs on cellular behavior need critical evaluation. In this review, the interactions between several types of mostly used NMs and stem cells, and their associated possible mechanisms are systematically discussed, with specific emphasis on the possible differentiation effects induced by NMs. It is expected that the enhanced understanding of NM-stem cell interactions will facilitate biomaterial design for stem-cell-therapy and regenerative medicine applications. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35542058 PMCID: PMC9080527 DOI: 10.1039/c8ra02424c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1The interaction of stem cells with various nanotopographical surface. (a) Stem cells interaction with nanostructure scaffolds. (b) Nanopatterned surface to mediate stem cells behaviors.
Fig. 2Schematic illustration of nanomaterial interactions with stem cells. These interactions can stimulate the differentiation of stem cells to a variety of tissues including but not limited to nerve, muscle, skin, liver and bone.
Fig. 3Representative TEM images (A) and size distribution histogram (B) of PLGA-BSA particles. (C) ALP activity of pristine MSCs (control), MSCs cultured in particle-free medium for 7 d (−PLGA) and PLGA-BSA particles for 7 d (+PLGA). (D) Western blot analysis of osteogenic markers (OCN and COL) and adipogenic markers (PPARg and LPL) expressed by pristine MSCs (control), MSCs cultured in particle-free medium for 21 d (−PLGA) and PLGA-BSA particles for 21 d (+PLGA) (E) western blot analysis of MAPK pathway related proteins (p38, JNK1/2, ERK1/2) expressed by pristine MSCs (control), MSCs cultured in particle-free medium for 7 d (−PLGA) and PLGA-BSA particles for 7 d (+PLGA). The particle concentration used here was 50 μg mL−1. * and ** indicate significant difference at p < 0.05 and p < 0.01 levels, respectively. Reproduced with permission.[102] Copyright 2015, Royal Society of Chemistry.
Fig. 4Silicate nanoplatelets could induce osteogenic differentiation of stem cells in the absence of osteogenic factors. (A) TEM image of silicate nanoplatelets. The silicate nanoplatelets are disc shaped nanoparticle with 25.4 nm in diameter. (B) Cellular uptake of silicate nanoplatelets with different concentrations (0, 1, 10 and 100 μg mL−1). (C) The metabolic activity of hMSCs in the presence of silicate nanoplatelets in the media at 48 hours of post seeding. The metabolic activity was normalized with the control (without NPs). The dotted line shows fitted dose response curve, and the IC50 was found at a silicate concentration of 4 mg mL−1. (D) Silicate nanoplatelets enhanced expression of RUNX2, osteopontin, osteocalcin, and matrix mineralization of MSCs incubated in normal growth medium. Reproduced with permission.[116] Copyright 2013, Wiley.
Fig. 5(A) Molecular mechanism of the modulation of osteogenic and adipocytic differentiation of MSCs by AuNPs through p38 MAPK signaling pathway. Reproduced with permission.[144] Copyright 2010, American Chemical Society. (B) ALP staining and activity level during the process of differentiation from ADSCs toward osteoblasts for 3 weeks: ALP stained cells, which were treated with osteogenic medium alone (control), BMP-2, and each size of GNPs for 3 weeks as observed by an optical microscope. Reproduced with permission.[146] Copyright 2014, Elsevier. (C) Schematic illustrations of the fabrication process of Au4-mPEG NPs, and the possible molecular mechanism of the inhibitive effect of Au4-mPEG NPs on osteogenic differentiation and their promotive effect on adipogenic differentiation. Reproduced with permission.[148] Copyright 2017, Royal Society Chemistry. (D) Schematic diagrams of the effects of the surface chirality at the nanoscale on osteogenic differentiation of MSCs. Reproduced with permission.[150] Copyright 2016, Springer.
Fig. 6Iron NPs accelerate osteogenic differentiation of MSCs via modulation of long noncoding RNA INZEB2. (A) TEM image of IONPs. (B) Size distribution histogram of IONPs. (C) The hysteresis loop of IONPs. WB and AC represent IONPs that were synthesized in heat mode in a water bath and in an alternating-current (AC) magnetic field. (D) Effects of different concentrations of Fe3+ on the ALP activity of MSCs. (E) Alizarin Red S staining images. MSC were treated with 100 μM Fe3+, 100 μg mL−1 IONPs, or osteogenesis-inducing supplements (OS) for 21 days. (F) Effects on ALP activity of MSCs after transfection with the indicated siRNA. (G) Alizarin Red S staining images. Effects on the mineralized-nodule formation in MSCs after transfection with the indicated siRNA. (H) Effects on the protein levels measured by western blotting after transfection with the indicated siRNA. All bars represent mean ± SD, n = 3, **p < 0.01; ***p < 0.001. Reproduced with permission.[157] Copyright 2017, Springer.
Summary of NP-mediated stem cell differentiation
| Nanomaterials (NMs) | Differentiation Potential | Oxidative Stress dependent | Mechanical Induction Dependent | Pathway | Cell Type | Ref. | ||
|---|---|---|---|---|---|---|---|---|
| Soft NMs | Polymeric NMs | PLGA-BSA | Promote osteogenic, impair adipogenic differentiation | — | Suggested | p38 mitogen-activated protein kinase pathway | MSCs |
|
| Hard NMs | Ceramic NMs | Mono-SMBGs | No | — | — | — | MSCs, ADSCs |
|
| HAP NPs (20 nm) | Promote osteogenic differentiation | — | — | — | MSCs |
| ||
| Nanosilicates | Promote osteogenic differentiation | — | — | — | ADSCs |
| ||
| Carbon NMs | SWCNTs | Promote adipogenic, osteogenic, chondrogenic | — | — | — | MSCs |
| |
| Hard NMs | Carbon NMs | SWCNTs | Promote neurogenic differentiation | — | — | — | MSCs |
|
| Neurogenic differentiation | — | — | Neurotrophin signaling pathway | MSCs |
| |||
| MWCNTs | Inhibit osteogenic, adipogenic differentiation | No | — | Smad-dependent BMP signaling pathway | PC12 cells |
| ||
| rGO nanosheets | Promote osteogenic differentiation | — | — | — | MSCs |
| ||
| Hard NMs | Carbon NMs | GO (hundreds of nanometers to several mircometers) | Enhance dopamine neural differentiation | — | — | — | Mouse embryonic stem cells (ESCs) |
|
| GO (400 nm) | Enhance neurogenesis | — | — | — | Human fetal neural stem cells (hfNSCs) |
| ||
| Hard NMs | Carbon NMs | Nanodiamonds | No | — | — | — | Embryonal |
|
| Metal/metal oxide NMs | Citrate-AuNPs | Promote osteogenic and inhibit adipogenic differentiation | — | — | — | Human fetal neural stem cells (hfNSCs) |
| |
| Chitosan-AuNPs | Promote osteogenic differentiation | — | Suggested | P38 mitogen-activated protein kinase | MSCs |
| ||
| Citrate-AuNPs (15–100 nm) | Promote osteogenic differentiation | — | — | Wnt/β-catenin | ADSCs |
| ||
| Hard NMs | Metal/metal oxide NMs | BSA-AuNPs (70, 100 nm) | Promote osteogenic differentiation | — | Suggested | — | MSCs |
|
| BSA-AuNPs (40 nm) | Inhibit osteogenic differentiation | — | Suggested | — | MSCs |
| ||
| BSA coated gold nanostars (40–110 nm) | No | — | Suggested | — | MSCs |
| ||
| BSA coated gold nanorods (70 nm) | Promote osteogenic differentiation | — | Suggested | — | MSCs |
| ||
| Hard NMs | Metal/metal oxide NMs | PEG-AuNPs (40 nm) | Promote osteogenic differentiation | — | Suggested | — | MSCs |
|
| PEG-AuNPs (4 nm) | Inhibit osteogenic and promote adipogenic differentiation | Suggested | Suggested | — | MSCs |
| ||
| AuNP–NH2 (21 nm), AuNP–OH (12 nm) | No | — | — | — | MSCs |
| ||
| Hard NMs | Metal/metal oxide NMs | AuNP–COOH (17 nm) | Inhibit osteogenic differentiation | — | — | — | MSCs |
|
|
| Enhance osteogenic differentiation | — | Suggested | P38 MAPK | MSCs |
| ||
| AgNPs | Promote osteogenic differentiation | — | Suggested | — | Urine-derived stem cells |
| ||
| PVP-AgNPs | No | — | — | — | MSCs |
| ||
| ZnO NPs | Promote osteogenic differentiation | — | — | — | MSCs |
| ||
| Hard NMs | Metal/metal oxide NMs | TiO2 NPs | Promote neural differentiation | — | — | — | NSCs |
|
| TiO2–COOH NRs | No | — | — | — | MSCs |
| ||
| CuO NPs | No | — | — | — | MSCs |
| ||
| CeO2 NPs (40, 60 nm) | Accelerate adipogenic transdifferentiation | — | — | — | Osteoblasts |
| ||